anti-CEA-CAR-T
/ Shanghai First Song Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 21, 2024
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=9 | Recruiting | Sponsor: China Medical University, China | Not yet recruiting ➔ Recruiting
Enrollment open • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • CEACAM5
August 28, 2023
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: China Medical University, China
CAR T-Cell Therapy • Metastases • New P1 trial • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • CEACAM5
1 to 2
Of
2
Go to page
1